+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Convalescent Plasma Therapy Market Report 2026 - Product Thumbnail Image

Convalescent Plasma Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Bispecific Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bispecific Antibodies Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
From
COVID-19 Current Therapy Market Report 2026 - Product Thumbnail Image

COVID-19 Current Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Biomanufacturing Market - Global Strategic Business Report - Product Thumbnail Image

Biomanufacturing Market - Global Strategic Business Report

  • Report
  • May 2026
  • 375 Pages
  • Global
From
From
From
Diagnostic Enzyme Market Report 2026 - Product Thumbnail Image

Diagnostic Enzyme Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Oncolytic Virus Therapy Market Report 2026 - Product Thumbnail Image

Oncolytic Virus Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator